1. Welsh MJ, Rogers CS, Stoltz DA, Meyerholz DK, Prather RS. Development of a porcine model of cystic fibrosis. Transactions of the American Clinical and Climatological Association. 120:149-162, 2009.

2. Butler JE, Lager KM, Splichal I, Francis D, Kacskovics I, Sinkora M, Wertz N, Sun J, Zhao Y, Brown WR, DeWald R, Dierks S, Muyldermans S, Lunney JK, McCray PB, Rogers CS, Welsh MJ, Navarro P, Klobasa F, Habe F, Ramsoondar J. The piglet as a model for B cell and immune system development. Veterinary Immunology and Immunopathology. 128 (1-3): 147-170, 2009.

3. Rogers CS, Stoltz DA, Meyerholz DK, Ostedgaard LS, Rokhlina T, Taft PJ, Rogan MP, Pezzulo AA, Karp PH, Itani OA, Kabel AC, Wohlford-Lenane CL, Davis GJ, Hanfland RA, Smith TL, Samuel M, Wax D, Murphy CN, Rieke A, Whitworth K, Uc A, Starner TD, Brogden KA, Shilyansky J, McCray PB Jr., Zabner J, Prather RS, Welsh MJ. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science. 321 (5897): 1837-41, 2008.

4. Rogers CS, Abraham WM, Brogden KA, Engelhardt JF, Fisher J, McCray Jr. PB, McLennan G, Meyerholz DK, Namati E, Ostedgaard LS, Prather RS, Stoltz DA, Zabner J and Welsh MJ. The Porcine Lung as a Potential Model for Cystic Fibrosis. AJP-Lung, 295 (2):L240-263, 2008.

5. Sun X, Yan Z, Yi Y, Lei D, Rogers CS, Chen J, Zhang Y, Welsh MJ, Leno GH, Engelhardt JF. Adeno-associated virus-targeted disruption of the CFTR gene in cloned ferrets. Journal of Clinical Investigation. 118 (4): 1578-83, 2008.

6. Rogers CS, Hao, Rokhlina T, Samuel M, Stoltz DA, Li Y, Petroff E, Vermeer DW, Kabel AC, Yan Z, Spate L, Wax D, Murphy CN, Rieke A, Whitworth K, Linville ML, Korte SW, Engelhardt JF, Welsh MJ, and Prather RS. Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer. Journal of Clinical Investigation. 118 (4): 1571-7, 2008.

7. Ostedgaard LS, Rogers CS, Dong Q, Randak CO, Vermeer DW, Rokhlina T, Karp PH, and Welsh, MJ. Processing and function of CFTR-ΔF508 are species-dependent. Proceedings of the National Academy of Sciences.104 (39) 15370-15375, 2007.

8. Lundquist AL, Manderfield LJ, Vanoye CG, Rogers CS, Donahue BS, Chang PA, Drinkwater DC, Murray KT, and George AL, Jr. Expression of multiple KCNE genes in human heart may enable variable modulation of IKs. Journal of Molecular and Cellular Cardiology. (38) 277-287, 2005.

9. Rogers CS, Vanoye CG, Sullenger BA, and George AL. Functional repair of a mutant chloride channel using trans-splicing ribozymes. Journal of Clinical Investigation. 110 (12) 1783-89, 2002.

10. Rogers CS, Sullenger BA, and George AL. Chapter 5: Gene Therapy. In Hardman JG and Limbird LE (Eds) Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 10th Edition, New York, McGraw-Hill, 2001.